Difference between revisions of "CD20"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
{{ Infobox immunostain | |||
| Name = {{PAGENAME}} | |||
| Image = | |||
| Width = | |||
| Caption = | |||
| Abbrev = | |||
| Synonyms = | |||
| Similar = CD79a | |||
| Clones = | |||
| Use = B-cell lymphomas | |||
| Subspecial = [[hematopathology]] | |||
| Pattern = | |||
| Positive = most B-cell lymphomas | |||
| Negative = | |||
| Other = | |||
}} | |||
'''CD20''' is a B-cell marker. It is positive in most B-cell lymphoma. | '''CD20''' is a B-cell marker. It is positive in most B-cell lymphoma. | ||
Revision as of 15:38, 5 March 2017
| CD20 | |
|---|---|
| Immunostain in short | |
| Similar stains | CD79a |
| Use | B-cell lymphomas |
| Subspeciality | hematopathology |
| Positive | most B-cell lymphomas |
CD20 is a B-cell marker. It is positive in most B-cell lymphoma.
Lymphomas
Negative B cell lymphomas
- Plasmablastic lymphoma.[1]
- ALK+ large B-cell lymphoma.
- Classical Hodgkin's lymphoma.
See also
References
- ↑ Teruya-Feldstein, J.; Chiao, E.; Filippa, DA.; Lin, O.; Comenzo, R.; Coleman, M.; Portlock, C.; Noy, A. (Nov 2004). "CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients.". Ann Oncol 15 (11): 1673-9. doi:10.1093/annonc/mdh399. PMID 15520070.